Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 03:52PM ET
5.14
Dollar change
-0.15
Percentage change
-2.84
%
Index- P/E- EPS (ttm)-0.88 Insider Own8.34% Shs Outstand31.15M Perf Week-1.91%
Market Cap163.50M Forward P/E- EPS next Y-0.88 Insider Trans0.00% Shs Float29.16M Perf Month-3.56%
Income-24.31M PEG- EPS next Q-0.36 Inst Own15.15% Short Float15.66% Perf Quarter-19.56%
Sales27.10M P/S6.03 EPS this Y-41.93% Inst Trans7.69% Short Ratio11.99 Perf Half Y23.56%
Book/sh0.58 P/B8.81 EPS next Y25.30% ROA-47.07% Short Interest4.57M Perf Year7.76%
Cash/sh1.25 P/C4.10 EPS next 5Y- ROE-197.34% 52W Range2.68 - 8.22 Perf YTD5.11%
Dividend Est.- P/FCF- EPS past 5Y30.59% ROI-105.43% 52W High-37.48% Beta4.04
Dividend TTM- Quick Ratio1.57 Sales past 5Y339.72% Gross Margin95.71% 52W Low91.79% ATR (14)0.39
Dividend Ex-Date- Current Ratio1.57 EPS Y/Y TTM25.02% Oper. Margin-95.73% RSI (14)41.43 Volatility8.97% 7.05%
Employees102 Debt/Eq0.29 Sales Y/Y TTM389.30% Profit Margin-89.72% Recom1.00 Target Price19.80
Option/ShortYes / Yes LT Debt/Eq0.25 EPS Q/Q-1.53% Payout- Rel Volume0.49 Prev Close5.29
Sales Surprise-49.41% EPS Surprise-172.65% Sales Q/Q64.29% EarningsMay 13 AMC Avg Volume380.68K Price5.14
SMA20-10.42% SMA50-9.06% SMA2009.18% Trades Volume182,057 Change-2.84%
Date Action Analyst Rating Change Price Target Change
May-17-24Initiated Oppenheimer Outperform $14
Jan-05-24Initiated Cantor Fitzgerald Overweight $8
Oct-26-22Initiated Ladenburg Thalmann Buy $15
Dec-26-18Downgrade Maxim Group Buy → Hold
Jan-26-18Reiterated H.C. Wainwright Buy $6.50 → $8.60
Sep-15-17Reiterated H.C. Wainwright Buy $2.15 → $6.50
Feb-13-17Resumed Rodman & Renshaw Buy $14
Jul-06-16Resumed H.C. Wainwright Buy $13
Jun-15-16Initiated ROTH Capital Buy
Jun-11-24 09:25AM
Jun-10-24 09:38AM
Jun-04-24 09:00AM
May-17-24 07:59AM
May-14-24 08:20AM
03:04AM Loading…
03:04AM
May-13-24 09:54PM
05:15PM
04:17PM
04:05PM
May-09-24 09:15AM
May-08-24 09:00AM
May-06-24 09:00AM
Apr-24-24 03:21PM
09:00AM
09:55AM Loading…
Apr-10-24 09:55AM
Mar-25-24 09:55AM
Mar-21-24 08:30AM
Mar-07-24 09:55AM
Mar-06-24 08:30AM
Mar-02-24 08:17AM
Mar-01-24 06:06AM
Feb-29-24 04:42PM
04:35PM
04:05PM
Feb-27-24 08:30AM
Feb-22-24 08:30AM
Feb-20-24 08:30AM
Jan-24-24 09:15AM
Dec-11-23 09:00AM
08:28AM Loading…
Nov-16-23 08:28AM
Nov-14-23 04:30PM
04:05PM
Nov-07-23 09:15AM
Nov-02-23 10:00AM
Oct-25-23 09:35AM
Oct-24-23 09:35AM
Oct-19-23 04:01PM
Oct-10-23 09:00AM
Sep-29-23 07:35AM
07:30AM
Sep-06-23 09:00AM
Aug-08-23 01:44PM
Aug-07-23 04:51PM
04:05PM
Aug-02-23 04:01PM
Jul-24-23 08:30AM
Jul-13-23 08:30AM
Jul-06-23 12:27PM
Jun-30-23 09:25AM
Jun-13-23 09:15AM
Jun-09-23 11:28AM
Jun-07-23 09:15AM
May-13-23 09:18AM
May-11-23 04:22PM
04:01PM
May-04-23 09:00AM
Apr-27-23 09:00AM
Mar-23-23 09:25AM
Mar-20-23 11:27AM
Mar-18-23 03:12AM
Mar-15-23 04:01PM
Mar-08-23 09:00AM
Mar-02-23 09:15AM
Feb-16-23 09:25AM
Jan-25-23 08:00AM
Jan-19-23 04:05PM
Jan-12-23 12:55PM
09:26AM
Jan-11-23 12:00PM
Dec-10-22 07:46AM
Nov-30-22 10:35AM
Nov-13-22 07:18AM
Nov-10-22 05:15PM
04:30PM
04:01PM
Nov-03-22 04:01PM
Oct-06-22 09:00AM
Sep-07-22 08:00AM
Aug-10-22 04:05PM
Aug-03-22 08:00AM
Jul-19-22 09:15AM
Jun-27-22 07:00AM
Jun-17-22 09:00AM
May-25-22 09:00AM
May-18-22 09:00AM
May-10-22 04:01PM
May-03-22 08:30AM
May-02-22 10:08AM
Mar-29-22 09:00AM
Mar-28-22 12:06PM
08:30AM
Mar-11-22 08:00AM
Mar-10-22 04:01PM
Mar-03-22 09:15AM
Mar-02-22 09:00AM
Feb-15-22 06:27AM
Jan-25-22 02:58PM
11:06AM
05:00AM
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLLIER EARL M JRDirectorApr 23 '24Option Exercise1.3930,00041,70056,856Apr 25 09:15 AM
Musket David BDirectorApr 23 '24Option Exercise1.3916,15622,45747,692Apr 24 01:30 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICEROct 23 '23Option Exercise1.392,1783,0272,381Oct 24 09:25 AM
Musket David BDirectorOct 12 '23Buy2.754101,12831,536Oct 13 01:59 PM
COLLIER EARL M JRDirectorOct 10 '23Buy2.8310,00028,30026,856Oct 12 09:15 AM
Musket David BDirectorOct 09 '23Buy2.825,08314,33431,126Oct 11 09:15 AM
Auwaerter Paul GisbertDirectorOct 06 '23Buy2.845,00014,2005,000Oct 10 09:15 AM
Musket David BDirectorOct 04 '23Buy2.902,5007,25026,043Oct 06 09:15 AM
Litvack FrankDirectorAug 14 '23Option Exercise1.3920,74828,840137,633Aug 16 05:00 PM